they grow older in the Iranian society, and develop multiple diseases requiring treatment with several medicines. In turn, this creates the need for integrated care across medical specialties and effective collaboration within a team of health professionals. The pharmacist is an important member of this team, with an important role to play in understanding and managing the complex patients, especially with respect to responsible medicines use.
It is imperative that complexity is also considered from the perspective of the patient, who may or may not consider themselves "complex". For each person, their primary concern is how their illness, and secondary to that, their medicine are taking care. Dr Timothy Chen, associate professor at the University of Sydney specialising in mental health, says that it is known, for example, that pharmacists often feel more comfortable and confident contributing to the management of physical conditions, such as cardiovascular disorders, than mental disorders. He explains that the global disease burden arising from mental illness is immense. Although there are different modes of management for mental disorders (eg. psychotherapy), drug therapy is the major modality of treatment for many conditions, such as depression, bipolar disorder and schizophrenia. Therefore pharmacists, as experts in pharmacotherapy, should have a major role in the management of mental illness.
Equally, there are many other factors that can make the management of patients with a mental illness more complex. Examples include the high rate of medication non-adherence (estimated to be approximately 50%) in patients prescribed antidepressant and other psychotropic medicines and the burden of managing significant adverse effects, such as diabetes, weight gain and dyslipidaemia. Although there are many challenges in the management of mental illness, pharmacists should and do have a major role to play in the delivery of effective health care.
Pharmacological management in these circumstances is challenging, with a host of issues including the number of medications required, the risk of drug-drug interactions and the need to minimise drug toxicity.
Nowhere do pharmacists interact with complex patients more than in the community. Pharmacists should be at the core of partnerships when it comes to managing diseases in the community such as GI disorders, high blood pressure, asthma, monitoring patients, performing triage, advising about treatment options and preventing additional complexities.
Although a great deal of action has taken place with the incorporation of clinical pharmacy course in the general pharmacy education curriculum, but a serious demand is obvious to take action for in-practice pharmacies with the arrangement of continues education programs with headings such as; why patients are complex, needs of complex patients, how these needs are currently being met, and emerging and future strategies for treating the complex patients. By providing evidence-based scientific information and embracing collaborative practice, the pharmacist should have a critical role in dealing with complexity in patient care. 
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